Sumitomo Pharma
(OTC) DNPUF
Sumitomo Pharma Financials at a Glance
Market Cap
$5.45B
Revenue (TTM)
$455.20B
Net Income (TTM)
$111.35B
EPS (TTM)
$1.88
P/E Ratio
7.32
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Price
$13.73
Volume
441
Open
$13.73
Price
$13.73
Volume
441
Open
$13.73
Previous Close
$13.73
Daily Range
$13.73 - $13.73
52-Week Range
$4.00 - $19.20
Dividend
$0.00
Beta (Volatility)
0.01 (Low)
Price
$13.73
Volume
441
Open
$13.73
Previous Close
$13.73
Daily Range
$13.73 - $13.73
52-Week Range
$4.00 - $19.20
DNPUF News
DNPUF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sumitomo Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
3,832
CEO
Toru Kimura, PhD
Website
www.sumitomo-pharma.co.jpHeadquarters
Osaka, 541-0045, JP
DNPUF Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
13%
Net Income Margin
24%
Return on Equity
51%
Return on Capital
10%
Return on Assets
13%
Earnings Yield
13.66%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.45B
Shares Outstanding
397.29M
Volume
441
Short Interest
0.00%
Avg. Volume
660.066
Financials (TTM)
Gross Profit
$245.40B
Operating Income
$14.93B
EBITDA
$38.59B
Operating Cash Flow
$16.50B
Capital Expenditure
$13.03B
Free Cash Flow
$3.47B
Cash & ST Invst.
$39.96B
Total Debt
$305.42B
Sumitomo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$120.73B
+7.4%
Gross Profit
$65.24B
-8.1%
Gross Margin
54.04%
N/A
Market Cap
$5.45B
N/A
Market Cap/Employee
$1.10M
N/A
Employees
4,980
N/A
Net Income
$8.82B
-83.5%
EBITDA
$19.21B
-30.1%
Quarterly Fundamentals
Net Cash
$201.81B
+30.2%
Accounts Receivable
$135.78B
+44.0%
Inventory
$82.35B
-23.3%
Long Term Debt
$259.18B
+117.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
13.50%
N/A
Return on Invested Capital
9.69%
N/A
Free Cash Flow
$22.98B
+2155.1%
Operating Cash Flow
$24.26B
+2484.0%